Rocket One (RKTO) slides below its 200‑day SMA, losing 32% in a month with low volume and no breakthrough in Hoth Therapeutics’ atopic dermatitis pipeline.
Rocket One’s 6.84% rally is driven by a new VCU partnership to develop low‑power spintronic AI chips, positioning the firm as a niche growth player in AI hardware.